CVS Health (BSP:CVSH34) EBIT: R$35,219 Mil (TTM As of Mar. 2026)


BSP:CVSH34 CVS Health Corp BSP:CVSH34
68 GF Score
Price R$52.70
GF Value R$40.19
Valuation Significantly Overvalued
! 10 Warning Signs
View Full Analysis

What is CVS Health EBIT?

CVS Health BSP:CVSH34 68 EBIT is R$35,219 Mil as of Mar. 2026. GuruFocus rates BSP:CVSH34 with a GF Score™ of 68/100 and a GF Value™ of R$40.19 (Significantly Overvalued). The stock has 10 warning signs investors should review.

CVS Health's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was R$24,642 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was R$35,219 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. CVS Health's annualized ROC % for the quarter that ended in Mar. 2026 was 7.45%. CVS Health's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 66.08%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. CVS Health's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 3.44%.

CVS Health  (BSP:CVSH34) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

CVS Health's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=97898.112 * ( 1 - 24.91% )/( (1013368.996 + 960761.194)/ 2 )
=73511.6923008/987065.095
=7.45 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1383227.267 - 446118.045 - ( 57819.509 - max(0, 483876.944 - 407617.17+57819.509))
=1013368.996

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1322952.83 - 422797.471 - ( 61719.739 - max(0, 451868.818 - 391262.983+61719.739))
=960761.194

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

CVS Health's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=98567.5/( ( (153065.119 + max(-230416.034, 0)) + (145267.829 + max(-207902.749, 0)) )/ 2 )
=98567.5/( ( 153065.119 + 145267.829 )/ 2 )
=98567.5/149166.474
=66.08 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(89015.201 + 105000.402 + 27774.969) - (446118.045 + 0 + 6088.561)
=-230416.034

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(105345.062 + 92929.992 + 22241.489) - (422797.471 + 0 + 5621.821)
=-207902.749

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

CVS Health's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=35218.533/1022977.722
=3.44 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CVS Health EBIT Related Terms

CVS Health EBIT Historical Data

* Premium members only.

The historical data trend for CVS Health's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CVS Health EBIT Chart

CVS Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 73,739.90 42,608.38 67,769.13 55,555.71 28,669.70

CVS Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19,589.06 13,365.38 -14,469.37 11,680.65 24,641.88

BSP:CVSH34 vs ELV, CI, HUM: EBIT Comparison

For the Healthcare Plans subindustry, CVS Health's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CVS Health EV-to-EBIT vs Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, CVS Health's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where CVS Health's EV-to-EBIT falls into.


BSP:CVSH34
68GF Score
CVS Health Corp BSP:CVSH34
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CVS Health EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was R$35,219 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of R$35,219 Mil mean?
CVS Health (BSP:CVSH34) has a EBIT of R$35,219 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on CVS Health.
Is CVS Health's EBIT too high?
CVS Health's current EBIT is R$35,219 Mil. Overall, CVS Health has a GF Score™ of 68/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does CVS Health's EBIT compare to ELV and CI?
CVS Health's EBIT of R$35,219 Mil can be compared against companies in the Healthcare Plans industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Plans company?
A good EBIT depends on the Healthcare Plans industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on CVS Health. CVS Health's current EBIT is R$35,219 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CVS Health stock overvalued right now?
Based on GuruFocus' analysis, CVS Health (BSP:CVSH34) is currently considered Significantly Overvalued. The stock's GF Value™ is R$40.19, compared to a current price of R$52.70 — trading 31.1% above its estimated fair value. The current EBIT is R$35,219 Mil. CVS Health's overall GF Score™ is 68/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For CVS Health (BSP:CVSH34), the current EBIT is R$35,219 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CVS Health (BSP:CVSH34) Overvalued in 2026?

Based on GuruFocus' analysis, CVS Health stock appears to be overvalued. The current stock price of R$52.70 is trading 31.1% above its estimated GF Value™ of R$40.19. GuruFocus considers CVS Health to be Significantly Overvalued.

Key valuation signals for BSP:CVSH34:

  • EBIT: R$35,219 Mil
  • GF Value™: R$40.19 vs. price of R$52.70 (31.1% above fair value)
  • GF Score™: 68/100 with 10 warning signs

No single metric tells the full story. See the BSP:CVSH34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CVS Health Business Description

Address One CVS Drive, Woonsocket, RI, USA, 02895
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates around 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.
68GF Score

Get the complete analysis for BSP:CVSH34

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$52.70
Price
R$40.19
GF Value